Cronos Group (CRON) vs Altria Group (MO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Altria Group (MO) has outperformed Cronos Group (CRON) over the past year, gaining 28.7% versus a gain of 28.3%. Over five years, MO leads with a +71.2% price change compared with -34.9% for CRON. Altria Group is the larger company by market cap ($124.54 billion vs $1.11 billion), about 111.8 times the size, while Cronos Group is growing revenue faster (+24.6% vs -3.1%).
On valuation, Altria Group trades at a lower trailing P/E (15.4x vs 19.0x for Cronos Group). Altria Group pays a dividend yielding 5.73%, while Cronos Group does not currently pay one. Altria Group converts more of its revenue into profit, with a net margin of 29.8% versus -6.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CRON | MO |
|---|---|---|
| Share price | $3.04 | $74.87 |
| Market cap | $1.11B | $124.54B |
| 1-day change | -1.30% | +0.25% |
| YTD return | +15.59% | +29.85% |
| 1-year return | +28.27% | +28.66% |
| 5-year return | -34.90% | +71.17% |
| P/E ratio (TTM) | 19.00 | 15.44 |
| Forward P/E | — | 12.64 |
| EPS (TTM) | $0.16 | $4.85 |
| Dividend yield | 0.00% | 5.73% |
| Annual dividend | $0.00 | $4.29 |
| Revenue (latest FY) | $146.59M | $23.28B |
| Revenue growth (YoY) | +24.63% | -3.08% |
| Net income (latest FY) | $-9.45M | $6.95B |
| Gross margin | 42.81% | 62.47% |
| Operating margin | -11.87% | 42.52% |
| Net margin | -6.44% | 29.84% |
| 52-week high | $3.91 | $79.97 |
| 52-week low | $2.35 | $54.70 |
| Distance from 52-week high | -22.25% | -6.38% |
| Analyst consensus | strong_buy | hold |
| Avg. price target upside | -3.62% | -1.90% |
| Average volume | 1.07M | 8.05M |
| Shares outstanding | 366.47M | 1.66B |
| Employees | 610 | 5,900 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Altria Group is about 111.8 times larger than Cronos Group by market value ($124.54B vs $1.11B).
- Altria Group offers a meaningfully higher dividend yield (5.73% vs 0.00%).
- Altria Group is more profitable, keeping 29.8 cents of every revenue dollar as net income versus -6.4 cents for Cronos Group.
- Cronos Group grew revenue faster in its latest fiscal year (+24.63% vs -3.08%).
About Cronos Group
CRON stock →Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names.
Health Care · Medicinal Chemicals and Botanical Products · 610 employees
About Altria Group
MO stock →Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. It offers cigarettes primarily under the Marlboro brand; large cigars and pipe tobacco under the Black & Mild brand; moist smokeless tobacco and oral tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands; oral nicotine pouches under the on! brand; and e-vapor products under the NJOY ACE brand.
Health Care · Medicinal Chemicals and Botanical Products · 5,900 employees
CRON vs MO FAQ
Which is bigger, Cronos Group or Altria Group?
Altria Group (MO) is larger, with a market capitalization of $124.54B compared with $1.11B for Cronos Group (CRON).
Which stock has performed better over the past year, CRON or MO?
MO returned +28.66% over the past 12 months, compared with +28.27% for CRON (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CRON or MO?
MO has the lower trailing P/E at 15.4, versus 19.0 for CRON. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cronos Group or Altria Group?
Altria Group pays a dividend yielding 5.73%, while Cronos Group does not currently pay a regular dividend.
Are Cronos Group and Altria Group in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.